| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/26/2013 | WO2013140071A1 Cyclosporin a-based aqueous ophthalmic solution |
| 09/26/2013 | WO2013139991A1 Pharmaceutical formulation comprising bendamustine |
| 09/26/2013 | WO2013139927A1 Composition for the treatment of pediculosis and corresponding manufacturing process |
| 09/26/2013 | WO2013139918A1 Topical application of ingenol mebutate with occlusion |
| 09/26/2013 | WO2013139906A1 Medicament for the treatment of acute myeloid leukemia (aml) |
| 09/26/2013 | WO2013139826A1 Pharmaceutical compositions comprising imatinib |
| 09/26/2013 | WO2013139695A1 Compositions comprising a delivery agent and preparation thereof |
| 09/26/2013 | WO2013139444A1 Ophthalmic pharmaceutical composition containing a carbonic anhydrase inhibitor and method for the preparation thereof |
| 09/26/2013 | WO2013139377A1 Method for producing enteric alginate microcapsules via ionic gelation containing diclofenac or one of the salts thereof and multiparticled pharmaceutical composition containing them |
| 09/26/2013 | WO2013139292A1 Joint product containing synephrine and topiramate |
| 09/26/2013 | WO2013139274A1 Sodium pyruvate oral rehydration salt composition for treating hypovolemia or hyponatration associated with hypohydration |
| 09/26/2013 | WO2013139266A1 Joint product containing phentermine and topiramate and preparation method therefor |
| 09/26/2013 | WO2013139209A1 Topiramate sustained-release pharmaceutical composition, method for preparing same, and use thereof |
| 09/26/2013 | WO2013139179A1 Tigecycline composition for injection |
| 09/26/2013 | WO2013139143A1 Salfaprodil crystal form, preparation method, and sterile powder containing salfaprodil crystal |
| 09/26/2013 | WO2013138930A1 Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo |
| 09/26/2013 | WO2013138916A1 Multi-functional micro and nanoparticles for use in root canal therapies |
| 09/26/2013 | WO2013116798A3 A method for the treatment and/or prevention of oral allergic symptoms of the lips due to oral contact with a food allergen |
| 09/26/2013 | WO2013073454A3 Controlled release composition for physiologically active substance |
| 09/26/2013 | WO2013052885A9 Prophylactic and post-acute use of progesterone in conjunction with its enantiomer for use in treatment of traumatic brain injuries |
| 09/26/2013 | WO2013041850A3 Inhalable microemulsion comprising anaesthetic |
| 09/26/2013 | US20130253449 Noradrenergic and specific serotonergic antidepressant-containing transdermal patch |
| 09/26/2013 | US20130253065 Inhalable Epinephrine |
| 09/26/2013 | US20130253017 Methods of Delivering a Health Care Active by Administering Personal Health Care Articles Comprising a Filmament |
| 09/26/2013 | US20130253003 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy |
| 09/26/2013 | US20130252995 Methods for reducing binge or compulsive eating |
| 09/26/2013 | US20130252985 Flavoring Systems for Pharmaceutical Compositions and Methods of Making Such Compositions |
| 09/26/2013 | US20130252916 Oramucosal pharmaceutical dosage form |
| 09/26/2013 | US20130252900 Microspheres useful for therapeutic vascular embolization |
| 09/26/2013 | US20130252511 Moisturizing fabric material, use thereof in moisturizing bras, and method of manufacture |
| 09/26/2013 | US20130251818 Personal lubricants |
| 09/26/2013 | US20130251817 Cancer cell targeting using nanoparticles |
| 09/26/2013 | US20130251816 Cancer cell targeting using nanoparticles |
| 09/26/2013 | US20130251814 Magnetic nanodrug for treating thrombosis |
| 09/26/2013 | US20130251813 Formulation of lacosamide |
| 09/26/2013 | US20130251812 Sequestered antagonist formulations |
| 09/26/2013 | US20130251811 Method for manufacturing medicinal compounds containing dabigatran |
| 09/26/2013 | US20130251810 Process for preparing orally administered dabigatran formulations |
| 09/26/2013 | US20130251808 Pharmaceutical composition, method of preparation and methods of treating aches/pains |
| 09/26/2013 | US20130251807 Micronized tanaproget, compositions, and methods of preparing the same |
| 09/26/2013 | US20130251805 Low viscosity liquid dosage forms |
| 09/26/2013 | US20130251804 Method to improve the safety of handling of high potency drugs in solid dosage forms without changing their efficacy |
| 09/26/2013 | US20130251803 Once daily formulation of lacosamide |
| 09/26/2013 | US20130251802 Tamper resistant dosage forms |
| 09/26/2013 | US20130251801 Tamper resistant dosage forms |
| 09/26/2013 | US20130251800 Tamper resistant dosage forms |
| 09/26/2013 | US20130251799 Tamper resistant dosage forms |
| 09/26/2013 | US20130251798 Tamper resistant dosage forms |
| 09/26/2013 | US20130251797 Tamper resistant dosage forms |
| 09/26/2013 | US20130251796 Tamper resistant dosage forms |
| 09/26/2013 | US20130251795 Pharmaceutical compositions containing a biguanide and a low dose antidiabetic agent |
| 09/26/2013 | US20130251794 Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same |
| 09/26/2013 | US20130251793 Pharmaceutical composition comprising phentermine and topiramate |
| 09/26/2013 | US20130251792 Encapsulation of heat and moisture sensitive substances |
| 09/26/2013 | US20130251791 Composition comprising a benzimidazole and process for its manufacture |
| 09/26/2013 | US20130251789 Tamper-resistant oral opioid agonist formulations |
| 09/26/2013 | US20130251788 Method of Inducing a Phase Transition of a Bilayer Membrane Vesicle |
| 09/26/2013 | US20130251785 Method and composition for treating cystitis |
| 09/26/2013 | US20130251783 Liposomes containing permeation enhancers for oral drug delivery |
| 09/26/2013 | US20130251782 Topical application of ingenol mebutate with occlusion |
| 09/26/2013 | US20130251779 New product |
| 09/26/2013 | US20130251777 Brachytherapy Seed |
| 09/26/2013 | US20130251763 Transdermal compositions |
| 09/26/2013 | US20130251762 Biomimetic scaffold for bone regeneration |
| 09/26/2013 | US20130251760 Transdermal Analgesic Systems with Reduced Abuse Potential |
| 09/26/2013 | US20130251759 Pharmaceutical dosage form |
| 09/26/2013 | US20130251757 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same |
| 09/26/2013 | US20130251735 Sclerostin and the inhibition of wnt signaling and bone formation |
| 09/26/2013 | US20130251683 Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagen |
| 09/26/2013 | US20130251674 Non-Aqueous Single Phase Vehicles and Formulations Utilizing Such Vehicles |
| 09/26/2013 | US20130251665 Treatment of chronic ulcerous skin lesions |
| 09/26/2013 | US20130251649 Method for preventing or treating skin tumor |
| 09/26/2013 | US20130251643 Abuse-proofed oral dosage form |
| 09/26/2013 | US20130251629 Nanoemulsion for the delivery of at least two agents of interest |
| 09/26/2013 | US20130249140 Method of producing a solid preparation |
| 09/26/2013 | US20130249131 Process for producing pellets for pharmaceutical compositions |
| 09/26/2013 | US20130248391 Convertible two compartment container |
| 09/26/2013 | US20130247376 Two-piece, internal-channel osmotic delivery system flow modulator |
| 09/26/2013 | DE102008043751B4 Verfahren zur Herstellung von großen Vesikeln aus selbstorganisierenden, membranbildenden Molekülen A process for the production of large vesicles of self-organizing, membrane-forming molecule |
| 09/25/2013 | EP2641605A1 Novel polymer derivative of cytidine metabolism antagonist |
| 09/25/2013 | EP2641599A1 Composition of an oral dosage form of vitamin E esters combination with enhanced antioxidant activity. |
| 09/25/2013 | EP2641598A2 Orally administered pharmaceutical composition for the treatment of irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, and digestive enzymes, and preparation method thereof |
| 09/25/2013 | EP2641595A1 Sublingual fentanyl spray |
| 09/25/2013 | EP2641594A2 Enteric coated solid pharmaceutical compositions for proton pump inhibitors |
| 09/25/2013 | EP2641593A2 Tablets |
| 09/25/2013 | EP2641592A1 Pharmaceutical formulation comprising bendamustine |
| 09/25/2013 | EP2641591A1 Synthesis of Starch Based Bioadhesive Polymers and Applications in Drug Carrier Systems |
| 09/25/2013 | EP2641590A1 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| 09/25/2013 | EP2640767A1 Method for preparing amide-initiated polymers having a varied architecture |
| 09/25/2013 | EP2640418A1 Immunogenic compositions |
| 09/25/2013 | EP2640411A1 Anti-inflammatory compositions |
| 09/25/2013 | EP2640401A1 Compositions with antibacterial and wound healing activity |
| 09/25/2013 | EP2640397A1 Methods for the treatment of fibromyalgia and chronic fatigue syndrome |
| 09/25/2013 | EP2640389A1 Transdermal therapeutic system comprising buprenorphine |
| 09/25/2013 | EP2640379A2 Low dose cannabinoid medicaments |
| 09/25/2013 | EP2640370A2 Compositions for transdermal delivery of active agents |
| 09/25/2013 | EP2640365A1 Pharmaceutical composition comprising krebs cycle precursor salt, in particular citrate salt, and use thereof as a medicament |
| 09/25/2013 | EP2640364A1 Pharmaceutical composition comprising bicarbonate salt, and use thereof as a medicament in the treatment and/or prevention of urinary lithiasis and related diseases |
| 09/25/2013 | EP2640363A1 Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria |
| 09/25/2013 | EP2640362A1 Therapeutic compositions comprising rilpivirine hcl and tenofovir disoproxil fumarate |